Waters Parkerson & Co’s Pfizer PFE Stock Holding History

Waters Parkerson & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33M	Sell	96,842 -2,075	-2%	-$54.3K	0.12%	75
2026 Q1	$2.78M	Sell	98,917 -2,837	-3%	-$75.5K	0.14%	70
2025 Q4	$2.53M	Sell	101,754 -1,050	-1%	-$26.5K	0.12%	73
2025 Q3	$2.62M	Sell	102,804 -6,499	-6%	-$160K	0.13%	71
2025 Q2	$2.65M	Sell	109,303 -5,659	-5%	-$132K	0.13%	72
2025 Q1	$2.91M	Sell	114,962 -6,772	-6%	-$177K	0.16%	69
2024 Q4	$3.23M	Sell	121,734 -33,667	-22%	-$913K	0.17%	65
2024 Q3	$4.5M	Sell	155,401 -18,231	-10%	-$532K	0.23%	61
2024 Q2	$4.86M	Sell	173,632 -14,938	-8%	-$411K	0.26%	58
2024 Q1	$5.23M	Sell	188,570 -25,516	-12%	-$708K	0.27%	57
2023 Q4	$6.16M	Sell	214,086 -35,419	-14%	-$1.07M	0.34%	53
2023 Q3	$8.28M	Sell	249,505 -28,453	-10%	-$1.01M	0.5%	51
2023 Q2	$10.2M	Sell	277,958 -12,109	-4%	-$471K	0.58%	49
2023 Q1	$11.8M	Sell	290,067 -4,471	-2%	-$193K	0.7%	48
2022 Q4	$15.1M	Sell	294,538 -3,306	-1%	-$159K	0.91%	40
2022 Q3	$13M	Sell	297,844 -2,298	-0.8%	-$112K	0.87%	43
2022 Q2	$15.7M	Sell	300,142 -2,066	-0.7%	-$105K	0.99%	40
2022 Q1	$15.6M	Sell	302,208 -3,016	-1%	-$156K	0.87%	45
2021 Q4	$18M	Sell	305,224 -20,952	-6%	-$1.04M	0.95%	41
2021 Q3	$14M	Sell	326,176 -9,405	-3%	-$417K	0.81%	45
2021 Q2	$13.1M	Sell	335,581 -4,795	-1%	-$186K	0.76%	46
2021 Q1	$12.3M	Sell	340,376 -30,416	-8%	-$1.08M	0.76%	46
2020 Q4	$13.6M	Sell	370,792 -25,530	-6%	-$936K	0.91%	43
2020 Q3	$13.8M	Sell	396,322 -19,412	-5%	-$681K	1.04%	36
2020 Q2	$12.9M	Sell	415,734 -534	-0.1%	-$18.1K	1.05%	35
2020 Q1	$12.9M	Sell	416,268 -2,893	-0.7%	-$98.6K	1.25%	28
2019 Q4	$15.6M	Sell	419,161 -2,636	-0.6%	-$93.9K	1.17%	31
2019 Q3	$14.4M	Sell	421,797 -8,065	-2%	-$293K	1.16%	33
2019 Q2	$17.7M	Sell	429,862 -284	-0.1%	-$11.3K	1.43%	28
2019 Q1	$17.3M	Sell	430,146 -11,026	-2%	-$442K	1.46%	28
2018 Q4	$18.3M	Buy	441,172 +10,331	+2%	+$429K	1.76%	23
2018 Q3	$18M	Buy	430,841 +4,169	+1%	+$160K	1.47%	29
2018 Q2	$14.7M	Buy	426,672 +4,561	+1%	+$156K	1.26%	32
2018 Q1	$14.2M	Buy	422,111 +22,020	+6%	+$757K	1.25%	32
2017 Q4	$13.7M	Buy	400,091 +12,586	+3%	+$429K	1.16%	36
2017 Q3	$13.1M	Buy	387,505 +12,943	+3%	+$416K	1.16%	36
2017 Q2	$11.9M	Buy	374,562 +44,856	+14%	+$1.41M	1.1%	35
2017 Q1	$10.7M	Buy	329,706 +66,290	+25%	+$2.09M	1.01%	38
2016 Q4	$8.12M	Buy	263,416 +17,035	+7%	+$520K	0.82%	41
2016 Q3	$7.92M	Buy	246,381 +15,666	+7%	+$524K	0.81%	41
2016 Q2	$7.71M	Buy	230,715 +14,370	+7%	+$459K	0.83%	41
2016 Q1	$6.08M	Buy	216,345 +4,864	+2%	+$139K	0.67%	45
2015 Q4	$6.48M	Buy	211,481 +654	+0.3%	+$20.6K	0.74%	42
2015 Q3	$6.28M	Buy	210,827 +676	+0.3%	+$21.7K	0.8%	42
2015 Q2	$6.68M	Sell	210,151 -127	-0.1%	-$4.14K	0.78%	44
2015 Q1	$6.94M	Sell	210,278 -8,697	-4%	-$276K	0.81%	41
2014 Q4	$6.47M	Buy	218,975 +3,917	+2%	+$112K	0.77%	43
2014 Q3	$6.03M	Buy	215,058 +13,138	+7%	+$369K	0.72%	43
2014 Q2	$5.69M	Buy	201,920 +1,843	+0.9%	+$52.5K	0.68%	43
2014 Q1	$6.1M	Buy	200,077 +4,538	+2%	+$135K	0.75%	43
2013 Q4	$5.68M	Buy	195,539 +408	+0.2%	+$11.9K	0.7%	43
2013 Q3	$5.32M	Buy	195,131 +15,887	+9%	+$432K	0.72%	45
2013 Q2	$4.76M	Buy	+179,244	New	+$4.95M	0.69%	45

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Waters Parkerson & Co's PFE Position: Q2 2026 in Review

Waters Parkerson & Co reduced its Pfizer (PFE) stake by 2.1% in Q2 2026, selling an estimated $54.3K and leaving 96,842 shares worth $2.33M. The position accounts for 0.12% of the portfolio, ranked #75.

Waters Parkerson & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.3M in Q4 2018. 1,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Waters Parkerson & Co held 96,842 shares of Pfizer worth $2.33M as of Q2 2026.
Waters Parkerson & Co sold 2,075 Pfizer shares in Q2 2026, an estimated $54.3K.
Pfizer made up 0.12% of Waters Parkerson & Co's portfolio in Q2 2026, its #75 holding.
Waters Parkerson & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Waters Parkerson & Co's Pfizer position peaked at $18.3M in Q4 2018.
1,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.